EASD 24 - Dr Phyo Htoo (Harvard Medical School, Boston, MA, US) joins us to discuss a study investigating the comparative effectiveness of empagliflozin and glucagon-like peptide-1 receptor agonists in combination as compared to either medication alone in patients with type 2 diabetes.

Interview Questions:
1. What was the reasoning for this study?
2. What was the patient population and study design?
3. What are the key findings?
4. Were there any surprising or unexpected results?
5. Where are the knowledge gaps and what further research is required?

Recorded remotely from Boston, 2024.